1型糖尿病中胰腺β细胞自噬受损
该研究利用NOD小鼠和nPOD人类供体胰腺组织,发现1型糖尿病中胰岛大自噬/分泌自噬受损:糖尿病NOD小鼠自噬体增多但LC3-LAMP1共定位减少,人类1型糖尿病残存β细胞同样共定位减少,自身抗体阳性供体β细胞出现含氮致密环的终末溶酶体蓄积。
要点
- 1型糖尿病人类残存β细胞中LC3-LAMP1共定位减少,提示自噬流受损。
- 糖尿病NOD小鼠胰岛自噬体增多但溶酶体融合减少,氯喹不能进一步诱导蓄积。
- 自身抗体阳性供体β细胞出现含氮致密环终末溶酶体蓄积,早于临床高血糖。
核心结论
- 人类1型糖尿病存在胰岛大自噬/分泌自噬受损,NOD小鼠模型表现相似。
- 自身抗体阳性供体β细胞出现含外周氮的终末溶酶体蓄积,提示溶酶体内容物改变可能早于临床高血糖。
研究设计与样本
- 收集氯喹注射与未注射的非肥胖糖尿病抵抗(NOR)和小鼠非肥胖糖尿病(NOD)胰腺。
- 获取年龄和BMI匹配的人类器官供体胰腺组织切片(N=34),来自nPOD。
- 对12例人类胰腺组织切片电镜评估次级溶酶体和终末溶酶体,对5例进行能量色散X射线分析。
主要发现
- 糖尿病NOD小鼠胰岛自噬体数量较NOR小鼠增加(p=0.008)。
- 非糖尿病和糖尿病NOD小鼠胰岛p62均较NOR小鼠增加(p<0.001)。
- 糖尿病NOD小鼠胰岛LC3-LAMP1共定位较非糖尿病NOD(p<0.001)和NOR(p<0.001)均减少。
- 氯喹使NOR(p=0.003)和非糖尿病NOD(p<0.001)胰岛自噬体蓄积,但糖尿病NOD无此反应;氯喹使NOR的p62蓄积(p<0.001),NOD无此反应。
- 人类1型糖尿病供体残存β细胞LC3-LAMP1共定位较非糖尿病供体减少(p<0.001),且胰岛素原与LAMP1共定位减少(p<0.001);自身抗体阳性供体β细胞电镜显示含氮致密环终末溶酶体蓄积(p=0.002)。
临床怎么用
- 1型糖尿病胰岛β细胞存在自噬溶酶体通路障碍,可能参与β细胞损伤。
- 自身抗体阳性个体已出现溶酶体异常,提示自噬标志物或可用于早期监测。
局限性
- 人类组织为横断面观察,无法确定自噬受损与β细胞破坏的因果关系。
- NOD小鼠与人类1型糖尿病存在种属差异,结论外推需谨慎。
- 部分电镜和元素分析样本量较小(n=12和n=5)。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIMS/HYPOTHESIS: Pancreatic beta cells are subjected to exogenous damaging factors such as proinflammatory cytokines or excess glucose that can cause accumulation of damage-inducing reactive oxygen species during the pathogenesis of diabetes. We and others have shown that beta cell autophagy can reduce reactive oxygen species to protect against apoptosis. While impaired islet autophagy has been demonstrated in human type 2 diabetes, it is unknown if islet autophagy is perturbed in the pathogenesis of type 1 diabetes. We hypothesised that beta cell autophagy is dysfunctional in type 1 diabetes, and that there is a progressive loss during early diabetes development. METHODS: Pancreases were collected from chloroquine-injected and non-injected non-obese diabetes-resistant (NOR) and non-obese diabetic (NOD) mice. Age- and BMI-matched pancreas tissue sections from human organ donors (N = 34) were obtained from the Network for Pancreatic Organ Donors with Diabetes (nPOD). Tissue sections were stained with antibodies against proinsulin or insulin (beta cell markers), microtubule-associated protein 1 light chain 3 A/B (LC3A/B; autophagosome marker), lysosomal-associated membrane protein 1 (LAMP1; lysosome marker) and p62 (autophagy adaptor). Images collected on a scanning laser confocal microscope were analysed with CellProfiler and ImageJ. Secondary lysosomes and telolysosomes were assessed in electron micrographs of human pancreatic tissue sections (n = 12), and energy dispersive x-ray analysis was performed to assess distribution of elements (n = 5). RESULTS: We observed increased autophagosome numbers in islets of diabetic NOD mice (p = 0.008) and increased p62 in islets of both non-diabetic and diabetic NOD mice (p < 0.001) vs NOR mice. There was also a reduction in LC3-LAMP1 colocalisation in islets of diabetic NOD mice compared with both non-diabetic NOD (p < 0.001) and NOR mice (p < 0.001). Chloroquine elicited accumulation of autophagosomes in the islets of NOR (p = 0.003) and non-diabetic NOD mice (p < 0.001), but not in islets of diabetic NOD mice; and stimulated accumulation of p62 in NOR (p < 0.001), but not in NOD mice. We observed reduced LC3-LAMP1 colocalisation (p < 0.001) in residual beta cells of human donors with type 1 diabetes vs non-diabetic participants. We also observed reduced colocalisation of proinsulin with LAMP1 in donors with type 1 diabetes (p < 0.001). Electron microscopy also revealed accumulation of telolysosomes with nitrogen-dense rings in beta cells of autoantibody-positive donors (p = 0.002). CONCLUSIONS/INTERPRETATION: We provide evidence of islet macroautophagy/crinophagy impairment in human type 1 diabetes. We also document accumulation of telolysosomes with peripheral nitrogen in beta cells of autoantibody-positive donors, demonstrating altered lysosome content that may be associated with lysosome dysfunction before clinical hyperglycaemia. Similar macroautophagy impairments are present in the NOD mouse model of type 1 diabetes.
引用
- Muralidharan C, Conteh AM, Marasco MR, et al. Pancreatic beta cell autophagy is impaired in type 1 diabetes. Diabetologia. 2021. PMID: 33515072. doi:10.1007/s00125-021-05387-6
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。